These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 35080127

  • 1. Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers.
    Armstrong DG, Galiano RD, Orgill DP, Glat PM, Carter MJ, Di Domenico LA, Reyzelman AM, Zelen CM.
    Int Wound J; 2022 May; 19(4):932-944. PubMed ID: 35080127
    [Abstract] [Full Text] [Related]

  • 2. A multi-centre, single-blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers.
    Armstrong DG, Orgill DP, Galiano RD, Glat PM, DiDomenico LA, Carter MJ, Zelen CM.
    Int Wound J; 2022 May; 19(4):791-801. PubMed ID: 34418302
    [Abstract] [Full Text] [Related]

  • 3. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W, Cazzell S, Sigal F, Caporusso JM, Agnew PS, Hanft J, Dove C.
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [Abstract] [Full Text] [Related]

  • 4. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
    Armstrong DG, Orgill DP, Galiano RD, Glat PM, Kaufman JP, Carter MJ, DiDomenico LA, Zelen CM.
    Int Wound J; 2024 Apr; 21(4):e14882. PubMed ID: 38606794
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial.
    Armstrong DG, Orgill DP, Galiano RD, Glat PM, Kaufman JP, Carter MJ, DiDomenico LA, Zelen CM.
    Int Wound J; 2022 Aug; 19(5):1197-1209. PubMed ID: 35001559
    [Abstract] [Full Text] [Related]

  • 7. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
    Snyder RJ, Shimozaki K, Tallis A, Kerzner M, Reyzelman A, Lintzeris D, Bell D, Rutan RL, Rosenblum B.
    Wounds; 2016 Mar; 28(3):70-7. PubMed ID: 26978860
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of Omega-3-Rich Fish Skin in the Treatment of Chronic, Nonresponsive Diabetic Foot Ulcers.
    Lullove EJ, Liden B, Winters C, McEneaney P, Raphael A, Lantis Ii JC.
    Wounds; 2021 Jul; 33(7):169-177. PubMed ID: 33872197
    [Abstract] [Full Text] [Related]

  • 10. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM, Orgill DP, Serena T, Galiano R, Carter MJ, DiDomenico LA, Keller J, Kaufman J, Li WW.
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial.
    Serena TE, Bullock NM, Cole W, Lantis J, Li L, Moore S, Patel K, Sabo M, Wahab N, Price P.
    J Wound Care; 2021 May 01; 30(Sup5):S7-S14. PubMed ID: 33979229
    [Abstract] [Full Text] [Related]

  • 13. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
    Tettelbach W, Cazzell S, Reyzelman AM, Sigal F, Caporusso JM, Agnew PS.
    Int Wound J; 2019 Feb 01; 16(1):19-29. PubMed ID: 30136445
    [Abstract] [Full Text] [Related]

  • 14. Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.
    Lantis JC, Snyder R, Reyzelman AM, Van Gils CC, Sigal F, Vayser D, Caporusso JM, Cazzell S, Lavery LA, PriMatrix Study Group.
    J Wound Care; 2021 Jul 01; 30(Sup7):S18-S27. PubMed ID: 34256588
    [Abstract] [Full Text] [Related]

  • 15. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers.
    Zelen CM, Gould L, Serena TE, Carter MJ, Keller J, Li WW.
    Int Wound J; 2015 Dec 01; 12(6):724-32. PubMed ID: 25424146
    [Abstract] [Full Text] [Related]

  • 16. A Prospective Multicenter Study of a Weekly Application Regimen of Viable Human Amnion Membrane Allograft in the Management of Nonhealing Diabetic Foot Ulcers.
    Galiano RD, Orgill DP, Armstrong DG, Glat PM, Carter MJ, Zelen CM.
    Plast Reconstr Surg Glob Open; 2023 Oct 01; 11(10):e5291. PubMed ID: 37811353
    [Abstract] [Full Text] [Related]

  • 17. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M, Uzun G, Bennett M, Germonpré P, Smart D, Mathieu D.
    Diving Hyperb Med; 2016 Sep 01; 46(3):133-134. PubMed ID: 27723012
    [Abstract] [Full Text] [Related]

  • 18. Matched-cohort study comparing bioactive human split-thickness skin allograft plus standard of care to standard of care alone in the treatment of diabetic ulcers: A retrospective analysis across 470 institutions.
    Barbul A, Gurtner GC, Gordon H, Bakewell K, Carter MJ.
    Wound Repair Regen; 2020 Jan 01; 28(1):81-89. PubMed ID: 31587418
    [Abstract] [Full Text] [Related]

  • 19. A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers.
    Landsman AS, Cook J, Cook E, Landsman AR, Garrett P, Yoon J, Kirkwood A, Desman E.
    Foot Ankle Spec; 2011 Feb 01; 4(1):29-41. PubMed ID: 21135263
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trial.
    Snyder R, Nouvong A, Ulloa J, Wahab N, Treadwell T, Bruwer F, Naude L, McGuire J, Reyzelman AM, Graham T, AWBC Research Team:, Lessing R, Lullove E, Ozker E, Pham HT, Pasternac M, Cohen S.
    J Wound Care; 2024 Sep 02; 33(9):688-700. PubMed ID: 39287414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.